CHICAGO, IL – Sheridan Capital Partners (“Sheridan”) announced today that it has received an additional commitment from its sole investor for equity investments in lower middle market companies in the United States and Canada.
Sheridan’s second tranche of capital follows the success of its prior investments of $150 million, which is currently fully invested across 3 current platforms, 1 platform investment expected to close in Q1 2017, and 2 realized investments. The firm will continue to target investments between $10 and $50 million in equity in support of leveraged buyouts and recapitalizations of entrepreneurially led companies and closely held family businesses.
Jonathan Lewis, Managing Partner, said, “We are thrilled with the response to our efforts thus far, and we are grateful to our limited partners for their continued support of Sheridan. We look forward to partnering with management teams in order to drive long-term value creation across the healthcare sector.”
Sean Dempsey, Managing Director, added, “Sheridan has had a meaningful impact on each of its platform investments through a commitment to operations and, above all, true partnerships with management teams. We look forward to investing this fund, and to achieving the best possible outcomes for our companies, our management teams, and our investors.”
About Sheridan Capital Partners
Sheridan Capital Partners, headquartered in Chicago, Illinois, focuses on making private equity investments in leveraged buyouts, recapitalizations and large minority financings of growing lower middle market growth companies with enterprise values between $20 million and $150 million within the healthcare and consumer sectors.
Jonathan Lewis, Partner